# US 10,369,049 B1 · Probes having fiber taper and fluid collection channel for ophthalmic laser treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,369,049 B1
- Document ID: US10369049B1
- Status: Granted
- Kind: B1
- Application number: 15/999,167
- Filed: 2018-08-17
- Granted: 2019-08-06
- Earliest claimed: 2018-08-17
- Assignees: IRIDEX Corporation
- Applicants: Iridex Corporation
- Inventors: Howard Chen; George Marcellino
- Web page: https://patentgrep.com/patent/US10369049B1

## CPC

- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F 9/00821: {for coagulation}
- A61F 9/009: Auxiliary devices making contact with the eyeball and coupling in laser light, {e.g. goniolenses (apparatus for eye examination A61B3/0008)}
- A61B 18/22: the beam being directed along or through a flexible conduit, e.g. an optical fibre; {Couplings or} hand-pieces therefor
- A61B 2018/2205: {Characteristics of fibres}
- A61F 2009/00865: {Sclera}
- A61F 2009/00868: {Ciliary muscles or trabecular meshwork}
- A61F 2009/00872: {Cornea}
- A61F 2009/00891: {Glaucoma}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A treatment probe for treating an eye of a patient includes an elongate body that defines a handle and a treatment fiber that is housed within the elongate body. The treatment fiber is configured to deliver treatment light energy to the eye. A contact member is disposed on an end of the elongate body. The contact member has a contact surface for positioning on a surface of the eye, two side edges that are positioned on opposite sides of the contact surface, and a fluid channel. The contact surface conforms to the shape of the eye's sclera and the two side edges are shaped to direct fluid that is present on the surface of the eye toward the fluid channel when the contact member is moved laterally across the surface of the eye. The fluid aggregates within the fluid channel and contacts a distal end of the treatment fiber.

## Claims

### Claim 1

A treatment probe for treating an eye of a patient, the eye having, a sclera, the treatment probe comprising:
an elongate body defining a handle having a proximal end and a distal end;
a treatment fiber housed in the elongate body and configured for delivering treatment light energy to the eye from a distal end of the treatment fiber; and
a contact member disposed on an end of the elongate body, the contact member including:
a contact surface for positioning on a surface of the eye;
two side edges that are positioned on opposite sides of the contact surface; and
a fluid channel;
wherein the contact surface conforms to the shape of the sclera and the two side edges are shaped to direct fluid on the surface of the eye toward the fluid channel when the contact member is moved laterally across the surface of the eye such that the fluid aggregates within the fluid channel and contacts the distal end of the treatment fiber.

### Claim 2 (depends on 1)

The treatment probe of claim 1, wherein the two side edges of the contact member are angled or tapered toward the fluid channel so that a width of the contact surface is narrowest adjacent the fluid channel.

### Claim 3 (depends on 2)

The treatment probe of claim 2, wherein the contact surface has an hourglass or bowtie configuration that is configured to funnel the fluid toward the fluid channel to aggregate the fluid within the fluid channel.

### Claim 4 (depends on 3)

The treatment probe of claim 3, wherein the contact member has a top end and a bottom end that are positioned on opposite ends of the two side edges, and wherein the lop end has a greater width than the bottom end.

### Claim 5 (depends on 1)

The treatment probe of claim 1, wherein the distal end of the treatment fiber is centered within the fluid channel.

### Claim 6 (depends on 1)

The treatment probe of claim 1, wherein the fluid channel has an axial depth from the contact surface of between 3 μm and 300 μm.

### Claim 7 (depends on 1)

The treatment probe of claim 1, wherein the distal end of the treatment fiber includes an angle cut that is configured to bend the treatment light energy toward the eye so that the treatment light energy is delivered more perpendicularly to the eye.

### Claim 8 (depends on 1)

The treatment probe of claim 1, further comprising a fiber taper element that is coupled with the distal end of the treatment fiber, the fiber taper element having a larger egress diameter than an ingress diameter and the fiber taper element being configured to reduce a divergence angle of a light beam that is emitted from the treatment fiber.

### Claim 9 (depends on 8)

The treatment probe of claim 8, wherein the fiber taper element has a conical frustum shape.

### Claim 10 (depends on 8)

The treatment probe of claim 8, wherein the ingress diameter is between about 50 and 100 μm and the egress diameter is between about 600 and 1000 μm.

### Claim 11 (depends on 1)

The treatment probe of claim 1, wherein the contact surface comprises a reference structure that is alignable with a reference feature of the eye.

### Claim 12 (depends on 11)

The treatment probe of claim 11, wherein the reference feature of the eye comprises a limbus, and wherein the reference structure of the contact surface comprises an edge separated from the distal end of the treatment fiber by between 1.5 mm and 4.0 mm.

### Claim 13 (depends on 1)

The treatment probe of claim 1, wherein the eye has an optical axis, and wherein the treatment probe is configured so that when the contact surface is positioned on the surface of the eye, the treatment probe is oriented angularly offset from the optical axis of the eye and the treatment light energy is delivered angularly offset from the optical axis.

### Claim 14 (depends on 1)

The treatment probe of claim 1, wherein the treatment probe is configured to deliver a plurality of pulses of the light energy to the eye to induce a therapeutic response without coagulating tissue of the eye.

### Claim 15 (depends on 1)

The treatment probe of claim 1, wherein the treatment light energy is a laser beam.

### Claim 16 (depends on 1)

The treatment probe of claim 1, wherein the treatment light energy is a light emitting diode (LED).

### Claim 17

A method of treating an eye of a patient, the eye having a sclera, the method probe comprising:
providing a treatment probe comprising:
an elongate body having a proximal end and a distal end;
a treatment fiber housed in the elongate body; and
a contact member disposed on an end of the elongate body, the contact member including a contact surface, two side edges that are positioned on opposite sides of the contact surface, and a fluid channel;
positioning the contact surface of the contact member on a surface of the eye;
moving the contact member laterally across the surface of the eye; and
delivering treatment light energy from a distal end of the treatment fiber to treat tissue of the eye;
wherein the contact surface conforms to the shape of the sclera and the two side edges are shaped to direct fluid on the surface of the eye toward the fluid channel as the contact member is moved laterally across the surface of the eye in order to aggregate fluid within the fluid channel and thereby wet the distal end of the treatment fiber with the fluid.

### Claim 18 (depends on 17)

The method of claim 17, further comprising treating a ciliary process of the eye with the treatment light energy.

### Claim 19 (depends on 17)

The method of claim 17, further comprising applying an irrigation fluid to the surface of the eye, wherein the fluid that is directed toward the fluid channel includes the irrigation fluid.

### Claim 20 (depends on 17)

The method of claim 17, wherein delivering treatment light energy from the distal end of the treatment fiber comprises delivering a plurality of pulses of the light energy so as to induce a therapeutic response without coagulating the tissue of the eye.

### Claim 21 (depends on 20)

The method of claim 20, wherein the plurality of pulses are delivered while the contact member is moved laterally across the surface of the eye.

### Claim 22 (depends on 17)

The method of claim 17, wherein the eye has an optical axis, and wherein the method further comprises positioning the contact surface on the surface of the eye so that the treatment probe is oriented angularly offset from the optical axis and the treatment light energy is delivered angularly offset from the optical axis.

### Claim 23 (depends on 17)

The method of claim 17, wherein positioning the contact surface on the surface of the eye comprises positioning a reference structure of the contact surface in alignment with a reference feature of the eye.

### Claim 24 (depends on 23)

The method of claim 23, wherein the reference feature of the eye comprises a limbus, and wherein the reference structure of the contact surface comprises an edge separated from the distal end of the treatment fiber by between 1.5 mm and 4.0 mm.

### Claim 25 (depends on 17)

The method of claim 17, wherein the two side edges of the contact member are angled or tapered toward the fluid channel so that a width of the contact surface is narrowest adjacent the fluid channel.

### Claim 26 (depends on 25)

The method of claim 25, wherein the contact surface has an hourglass or bowtie configuration that is configured to funnel the fluid toward the fluid channel to aggregate the fluid within the fluid channel.

### Claim 27 (depends on 26)

The method of claim 26, wherein the contact member has a top end and a bottom end that are positioned on opposite ends of the two side edges, and wherein the top end has a greater width than the bottom end.

### Claim 28 (depends on 17)

The method of claim 17, wherein the distal end of the treatment fiber is centered within the fluid channel such that the distal end of the treatment fiber is fully wettable by the fluid aggregated within the fluid channel.

### Claim 29 (depends on 17)

The method of claim 17, wherein the fluid channel has an axial depth from the contact surface of between 3 μm and 300 μm.

### Claim 30 (depends on 17)

The method of claim 17, further comprising delivering the treatment light energy through an angle cut of the distal end of the treatment fiber to bend the treatment light energy away from an axis of the treatment fiber and toward the eye.

### Claim 31 (depends on 17)

The method of claim 17, further comprising delivering the treatment light energy through a fiber taper element that is coupled with the distal end of the treatment fiber to reduce a divergence angle of a light beam that is emitted from the treatment fiber, wherein the fiber taper element has a larger egress diameter than an ingress diameter.

### Claim 32 (depends on 31)

The method of claim 31, wherein the fiber taper element has a conical frustum shape.

### Claim 33 (depends on 31)

The method of claim 31, wherein the ingress diameter is between about 50 and 100 μm and the egress diameter is between about 600 and 1000 μm.